scholarly journals The Comparison of the Efficacy and Safety of Intralesional Triamcinolone Acetonide and Methotrexate Injections for the Treatment of Fingernail Psoriasis

2018 ◽  
Vol 71 (2) ◽  
pp. 145-151
Author(s):  
Pelin Üstüner ◽  
Ali Balevi ◽  
Mustafa Özdemir
Keyword(s):  
Triamcinolone Acetonide ◽  
Efficacy And Safety

Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients

2003 ◽  
Vol 211 (1-2) ◽  
pp. 81-84 ◽  
Author(s):  
Volker Hoffmann ◽  
Sebastian Schimrigk ◽  
Saida Islamova ◽  
Kerstin Hellwig ◽  
Carsten Lukas ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Triamcinolone Acetonide ◽  
Progressive Multiple Sclerosis ◽  
Efficacy And Safety ◽  
Multiple Sclerosis Patients

Efficacy and Safety of Triamcinolone Acetonide Aerosol in Chronic Asthma

CHEST Journal ◽  
1982 ◽  
Vol 81 (1) ◽  
pp. 20-26 ◽  
Author(s):  
I. Leonard Bernstein ◽  
Paul Chervinsky ◽  
Constantine J. Falliers
Keyword(s):  
Triamcinolone Acetonide ◽  
Chronic Asthma ◽  
Efficacy And Safety

Clinical Assessment of the Efficacy and Safety of Intralesional Injection of Triamcinolone Acetonide for Treatment of Chronic Radio Dermatitis

2017 ◽  
Vol 1 (2) ◽  
pp. 89-95
Author(s):  
Hanan Abdel Rady Assaf ◽  
Mohammed Abu El-Hamd ◽  
Essam Nada ◽  
Ahmed Marzouk Maklad ◽  
Asmaa A. Badran ◽  
...  
Keyword(s):  
Triamcinolone Acetonide ◽  
Clinical Assessment ◽  
Intralesional Injection ◽  
Efficacy And Safety

scholarly journals Efficacy and safety of intralesional triamcinolone acetonide in the treatment of chronic hand eczema

2017 ◽  
Vol 10 (3) ◽  
pp. 129
Author(s):  
Tasnuva Ashraf ◽  
Harashit Kumar Paul ◽  
Md. Shahidullah Sikder ◽  
A. S. M. Zakaria ◽  
Saiful Islam Bhuiyan ◽  
...  
Keyword(s):  
Triamcinolone Acetonide ◽  
Severity Index ◽  
Hand Eczema ◽  
Clobetasol Propionate ◽  
Controlled Clinical Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled ◽  
Chronic Hand Eczema ◽  
Group A ◽  
Group B

<p class="Abstract">This randomized controlled clinical trial was conducted to assess the efficacy and safety of intralesional triamcinolone acetonide in the treatment of chronic hand eczema comparing with topical clobetasol propionate. A total 60 patients of chronic hand eczema were recruited in the study. Thirty patients (Group A) were treated with intralesional triamcinolone acetonide and the rest 30 (Group B) with topical clobetasol propionate. Severity and improvement were assessed using Hand Eczema Severity Index (HECSI) score. The patients of both groups were followed up at 4<sup>th</sup> week and 12<sup>th</sup> week. In Group A, median HECSI score at baseline, 4<sup>th</sup> week and 12<sup>th</sup> week were 3, 20 and 20 respectively; whereas these scores were 54, 10 and 8 in Group B. In both groups, HECSI score was decreased gradually but the rate was higher in Group B than Group A (p&lt;0.05). Thinning of skin, an adverse effect, was seen in patients of both the intralesional triamcinolone acetonide (10%) and topical clobetasol propionate (16.7%) groups (p&gt;0.05). The result of this study demonstrates that intralesional triamcinolone acetonide is effective and safe in treating chronic hand eczema but less effective than the topical clobetasol.</p>

Sign in / Sign up

Export Citation Format

Share Document